Does CEG pay a dividend?
No, Celldex Therapeutics (NASDAQ: CLDX) does not pay a dividend to its shareholders. As a clinical-stage biotechnology company focused on the development of innovative therapeutics for diseases like cancer and inflammatory conditions, Celldex prioritizes the reinvestment of all available capital into its ongoing drug research, clinical trials, and pipeline development. Companies in the biotechnology and pharmaceutical research sector at this stage typically do not issue dividends, as they are focused on achieving long-term scientific and commercial milestones rather than distributing immediate cash to investors.
Related FAQs
Constellation Energy Corporation (CEG) operates as a leading carbon-free energy producer and nuclear power generator experiencing immense market attention due to direct clean energy supply contracts with artificial intelligence data centers.
Constellation Energy has occasionally navigated complex public policy debates, regulatory scrutiny over energy market pricing, and legislative discussions concerning nuclear power subsidies and grid reliability standards.
Jim Cramer has been an enthusiastic supporter of Constellation Energy, championing the power producer as a prime beneficiary of the massive surge in electricity demand driven by data centers and artificial intelligence training clusters.
Constellation Energy Corporation (traded under the ticker CEG) is widely viewed by Wall Street equity analysts as a favorable purchase, holding strong consensus buy ratings.
Yes, Warren Buffett’s Berkshire Hathaway purchased shares in D.R. Horton, one of the largest homebuilders in the United States, in 2025. The initial investment of approximately $191.
Constellation Software Inc. spun out Lumine Group Inc. in 2023.
CEG is the ticker symbol for Constellation Energy Corporation, a leading American energy company. As of August 2, 2026, the company is a major player in the energy sector, with a market capitalization of approximately $90.03 billion.